Subscribe To
IMUNON CEO Issues Letter to Shareholders
Reviews 2022 accomplishments; sets forth 2023 milestones and long-term vision LAWRENCEVILLE, N.J., March 01, 2023 (GLOBE NEWSWIRE) — IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage biotechnology company, today announced that Dr. Corinne Le Goff, the company’s president and chief executive officer, has issued the following letter to shareholders. To Our Shareholders: Several transformative events during 2022 […] The post IMUNON CEO Issues Letter to Shareholders appeared first on ForexTV...
Read More
Posted: Mar 1 2023, 13:45
Author Name: forextv
Views: 110998